L01XA Platinum compounds

L01XA01 CisplatinL01XA02 CarboplatinL01XA03 Oxaliplatin

L01XB Methylhydrazines

L01XB01 Procarbazine

L01XC Monoclonal antibodies

L01XC01 EdrecolomabL01XC02 RituximabL01XC03 TrastuzumabL01XC04 AlemtuzumabL01XC05 GemtuzumabL01XC06 CetuximabL01XC07 Bevacizumab

L01XD Sensitizers used in Photodynamic/Radiation therapy

L01XD01 Porfimer sodiumL01XD02 VerteporfinL01XD03 Methyl aminolevulinateL01XD04 Aminolevulinic acidL01XD05 TemoporfinL01XD06 Efaproxiral

L01XX Other antineoplastic agents

L01XX01 AmsacrineL01XX02 AsparaginaseL01XX03 AltretamineL01XX05 HydroxycarbamideL01XX07 LonidamineL01XX08 PentostatinL01XX09 MiltefosineL01XX10 MasoprocolL01XX11 EstramustineL01XX14 TretinoinL01XX16 MitoguazoneL01XX17 TopotecanL01XX18 TiazofurineL01XX19 IrinotecanL01XX22 AlitretinoinL01XX23 MitotaneL01XX24 PegaspargaseL01XX25 BexaroteneL01XX27 Arsenic trioxideL01XX28 ImatinibL01XX29 Denileukin diftitoxL01XX31 GefitinibL01XX32 BortezomibL01XX33 CelecoxibL01XX34 ErlotinibL01XX35 Anagrelide

L01XY Combinations of antineoplastic agents